{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-009595","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2025-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.208789+00:00","generated_at":"2026-05-27T22:24:43.601866+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MiNK Therapeutics stockholders approve 1-for-10 reverse stock split effective Jan 28","bullets":["Special meeting held Jan 17, 2025; 27,582,512 shares voted (quorum).","Proposal approved with 26,500,274 For, 1,026,255 Against, 56,013 Abstain.","Reverse split ratio 1-for-10, effective 12:01 a.m. ET on Jan 28, 2025.","Post-split shares trade under new CUSIP 603693 201 on Nasdaq.","39,630,402 shares outstanding pre-split as of record date Dec 16, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-009595","json":"https://secwatch.observer/filing/0001193125-25-009595.json","markdown":"https://secwatch.observer/filing/0001193125-25-009595.md","text":"https://secwatch.observer/filing/0001193125-25-009595.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000119312525009595/0001193125-25-009595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000119312525009595/d926991d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T22:24:43.601866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}